Paul Miller

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Vincent M. Isabella, Binh Ha, Mary Joan Castillo et al. · Nature Biotechnology · 2018 · 548 citations

Biosynthesis, Engineering, Biotechnology +6

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Daniel S. Leventhal, Anna Sokolovska, Ning Li et al. · Nature Communications · 2020 · 410 citations · Full text

An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

Caroline Kurtz, Yves Millet, Marja Puurunen et al. · Science Translational Medicine · 2019 · 366 citations

Bacterial uptake of aminoglycoside antibiotics.

Harry Taber, J P Mueller, Paul Miller et al. · Microbiological Reviews · 1987 · 197 citations

Antibiotics, Medicine, Antimicrobial Chemotherapy +7

The MarR Repressor of the Multiple Antibiotic Resistance (mar) Operon in Escherichia coli: Prototypic Member of a Family of Bacterial Regulatory Proteins Involved in Sensing Phenolic Compounds

Mark C. Sulavik, Laura Gambino, Paul Miller · Molecular Medicine · 1995 · 187 citations · Full text

Antimicrobial Resistance Gene, Health Sciences, Biochemistry +11